{"id":"W2983305723","doi":"10.1182/blood-2019-125810","title":"Treatment of Myeloma Patients Progressing on Lenalidomide-Based Maintenance after ASCT Performed As Part of 1st, 2nd or 3rd Line Therapy: Real-World Results from the National Myeloma Canada Research Network (MCRN) Database","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Saint John Regional Hospital; University of Alberta; Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Ottawa; McGill University Health Centre; Hôpital Maisonneuve-Rosemont; University of New Brunswick; Leukemia & Lymphoma Society of Canada; University of British Columbia; University of Calgary; Princess Margaret Cancer Centre; CancerCare Manitoba; Ottawa Hospital","funders":"","keywords":"Lenalidomide; Multiple myeloma; Medicine; Maintenance therapy; Oncology; Thalidomide; Pomalidomide; Internal medicine; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001607674,0.0004557119,0.001281859,0.002104921,0.0009429056,0.001183152,0.001727192,0.0005192413,0.001850554],"category_scores_gemma":[0.006505813,0.0002936703,0.001611387,0.01070722,0.0003655689,0.0004322485,0.0007786917,0.000744929,0.0002558115],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01612214,"about_ca_system_score_gemma":0.02063097,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.8865459,"about_ca_topic_score_gemma":0.9296426,"domain_scores_codex":[0.9973159,0.0002449152,0.0004348442,0.000551391,0.001060138,0.0003927164],"domain_scores_gemma":[0.9932198,0.0006898289,0.002867117,0.0004450847,0.002136206,0.0006420231],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00388722,0.0001235997,0.9569901,0.001323672,0.002239122,0.0001286462,0.0002553137,0.001037301,0.0002314848,0.0002588478,0.01708522,0.01643955],"study_design_scores_gemma":[0.0004856968,0.0001466098,0.9845197,0.0002846705,0.001580985,0.0002437374,0.000302726,0.001144851,0.00022504,0.00008305157,0.01093268,0.00005028539],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6557133,0.007731501,0.0003368548,0.0006394918,0.00003335598,0.0004131859,0.3317032,0.00004975817,0.003379398],"genre_scores_gemma":[0.7928572,0.003291823,0.001012964,0.0004529688,0.0000356817,0.0002357806,0.2014381,0.00001960125,0.0006557216],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8865459,"threshold_uncertainty_score":0.2282445,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07187631093639534,"score_gpt":0.3496937985569752,"score_spread":0.2778174876205799,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}